BridgeMD
Compares treatment options for Continuous Adductor Canal Block
Official title Effect of Continuous Adductor Canal Block Versus Continuous Adductor Canal Block With Additional Infiltration Between The Popliteal Artery and Capsule of The Knee (IPACK) After Arthroscopic Knee Surgeries
ClinicalTrials.gov ID: NCT06802419
What this study is testing
- What it's testing
- This study aims to evaluate the effect of Continuous Adductor Canal Block only versus adding posterior knee block, known as the Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) block with Continuous Adductor Canal Block (CACB) after arthroscopic knee surgeries.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 65
You may be able to join if
- Age from 21 to 65 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) Physical Status Class I to II.
- Patients with successful spinal anesthesia.
- Patients scheduled for elective arthroscopic knee surgery for anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) repair.
You likely can't join if
- Declining to give written informed consent.
- History of allergy to the medications used in the study.
- Contraindications to regional anesthesia (including coagulopathy and local infection).
- Polytrauma patients having lower limb fractures.
- Patients with pre-existing myopathy or neuropathy on the operating limb.
- Patients with diabetes mellitus.
See the full eligibility criteria
- Age from 21 to 65 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) Physical Status Class I to II.
- Patients with successful spinal anesthesia.
- Patients scheduled for elective arthroscopic knee surgery for anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) repair.
- Declining to give written informed consent.
- History of allergy to the medications used in the study.
- Contraindications to regional anesthesia (including coagulopathy and local infection).
- Polytrauma patients having lower limb fractures.
- Patients with pre-existing myopathy or neuropathy on the operating limb.
- Patients with diabetes mellitus.
- Psychiatric disorder.
- Morbid obesity [body mass index (BMI) \> 45kg/m2].
- Complicated Surgery.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.